NCT06325527Not yet recruiting
Cognitive Impairment Cohort Study of the Elderly Population in YuGarden
Shanghai Cognitive Impairment Study of the Elderly Population: YuGarden Cohort
Source: ClinicalTrials.gov · Last updated 22 Mar 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this prospective observational research with an 8-year follow-up is to study the cognitive changes in the elderly in YuGarden community, Shanghai, China. The main questions it aims to answer are: * incidence of cognitive impairment in community (converting to mild cognitive impairment or Alzheimer's disease) * to build a predictive model for the progression of cognitive impairment
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 1872 (estimated)
- First submitted
- 26 Feb 2024
- Start date
- 1 Apr 2024
- Primary completion date
- 1 Apr 2031
- Lead sponsor
- Ruijin Hospital
- Diseases
- Alzheimer disease
- NCT number
- NCT06325527
What you commit to
- Study type: Observational
- Planned participants: 1872
- From 1 Apr 2024 to the primary completion date, 1 Apr 2031
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Participants who are suffering from severe mental illness, tumor cachexia, severe liver and kidney dysfunction and other serious physical diseases and unable to cooperate with the examination.
- Participants who have visual or auditory impairment that hampers the completion of related examination.
Other
- Situations when magnetic resonance imaging or other examinations are contraindicated.
Who the study is looking for
- The participants are community-dwelling elderly people living in Yuyuan community, Shanghai, aged 60-85 years old, with no gender restriction.
- Non-AD patients.
- The participants can complete the cognitive tests, biological sample collection, speech tests, neuroimaging examinations, and cooperate with the implementation of the whole process of research.
- The participants agree to participate in this study and sign the informed consent form.
Age in the registry: 60 years to 85 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Coordinator of this site? Confirm its status | Shanghai | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.